Narjust Florez
MD
Associate Director of the Cancer Care Equity Program and Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Feb 25, 2025
Episode
263
Soundcloud
Share
In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion on how small cell lung cancer continues to evolve with new treatment options and recent FDA approval. Listen to the episode to learn about the current standard of care and future therapies, with a brief discussion about small cell transformation.
Guest
Jacob Sands
MD
Assistant Professor of Medicine, Harvard Medical School
Lowe Cancer Center for Thoracic Oncology
Dana Farber Cancer Institute
Triparna Sen
PhD
Associate Professor, Co-Director, Lung Cancer PDX Program, Department of Oncological Sciences
Icahn School of Medicine at Mount Sinai
Tisch Cancer Institute
